Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody

Molecular and Cellular Neuroscience

Volumn 24, Issue 4, 2003, Pages 1131-1150

  Savchenko, Valentina ^a   Sung, Uhna ^a   Blakely, Randy D ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANTIBODY; ANTIDEPRESSANT AGENT; ECTODOMAIN ANTIBODY; NORADRENALIN TRANSPORTER; PHORBOL ESTER; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL LABELING; CELL SURFACE; CERCOPITHECIDAE; CONTROLLED STUDY; DEPOLARIZATION; EMBRYO; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CELL; MALE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STIMULATION; SUPERIOR CERVICAL GANGLION; VARICOSIS;

EID: 0347124691     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00235-5     Document Type: Article

References (66)

1. Apparsundaram S., Schroeter S., Giovanetti E., Blakely R.D. Acute regulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins. J. Pharmacol. Exp. Ther. 287:1998;744-751.
2. Apparsundaram S., Sung U., Price R.D., Blakely R.D. Trafficking- dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J. Pharmacol. Exp. Ther. 299:2001;666-677.
3. Apparsundaram S., Galli A., DeFelice L.J., Hartzell H.C., Blakely R.D. Acute regulation of norepinephrine transport I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287:1998;733-743.
4. Barker E.L., Blakely R.D. Norepinephrine and serotonin transporters Molecular targets of antidepressant drugs . Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;321-333 Raven Press, New York.
5. Bauman A.L., Apparsundaram S., Ramamoorthy S., Wadzinski B.E., Vaughan R.A., Blakely R.D. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20:2000;7571-7578.
6. Bauman P.A., Blakely R.D. Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity. Arch. Biochem. Biophys. 404:2002;80-91.
7. Blakely R.D., Bauman A.L. Biogenic amine transporters regulation in flux . Curr. Opin. Neurobiol. 10:2000;328-336.
8. Bogan J.S., McKee A.E., Lodish H.F. Insulin-responsive compartments containing GLUT4 in 3T3-L1 and CHO cells regulation by amino acid concentrations . Mol. Cell. Biol. 21:2001;4785-4806.
9. Bönisch H., Hammermann R., Brüss M. Role of protein kinase C and second messengers in regulation of the norepinephrine transporter. Adv. Pharmacol. 42:1998;183-187.
10. Borowsky B., Hoffman B.J. Neurotransmitter transporters molecular biology, function, and regulation . Int. Rev. Neurobiol. 38:1995;139-199.
11. Boyd F.T., Clarke D.W., Muther T.F., Raizada M.K. Insulin receptors and insulin modulation of norepinephrine uptake in neuronal cultures from rat brain. J. Biol. Chem. 260:1985;15880-15884.
12. Brüss M., Kunz J., Lingen B., Bönisch H. Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter. Hum. Genet. 91:1993;278-280.
13. Brüss M., Hammermann R., Brimijoin S., Bönisch H. Antipeptide antibodies confirm the topology of the human norepinephrine transporter. J. Biol. Chem. 270:(16):1995;9197-9201.
14. Carneiro A., Ingram S.L., Beaulieu J.-M., Sweeney A., Amara S.G., Thomas S.M., Caron M.G., Torres G.E. The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J. Neurosci. 22:2002;7045-7054.
15. Chen J.-G., Lui-Chen S., Rudnick G. External cysteine residues in the serotonin transporter. Biochemistry. 36:1997;1479-1486.
16. Chen J.G., Liu-Chen S., Rudnick G. Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J. Biol. Chem. 273:1998;12675-12681.
17. Cochilla A.J., Angleson J.K., Betz W.J. Monitoring secretory membrane with FM1-43 fluorescence. Annu. Rev. Neurosci. 22:1999;1-10.
18. Daniels G.M., Amara S.G. Regulated trafficking of the human dopamine transporter clathrin-mediated internalization and lysosomal degradation in response to phorbol esters . J. Biol. Chem. 274:1999;35794-35801.
19. Deken S.L., Wang D., Quick M.W. Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling. J. Neurosci. 23:2003;1563-1568.
20. Ferrer J.V., Javitch J.A. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. Proc. Natl. Acad. Sci. USA. 95:1998;9238-9243.
21. Freedman L.J., Cassell M.D. Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Res. 633:1994;243-252.
22. Fritz J.D., Jayanthi L.D., Thoreson M.A., Blakely R.D. Cloning and chromosomal mapping of the murine norepinephrine transporter. J. Neurochem. 70:1998;2241-2251.
23. Galli A., DeFelice L.J., Duke B.J., Moore K.R., Blakely R.D. Sodium-dependent norepinephrine-induced currents in norepinephrinetransporter- transfected HEK-293 cells blocked by cocaine and antidepressants. J. Exp. Biol. 198:1995;2197-2212.
24. Gelernter J., Kruger S., Pakstis A.J., Pacholczyk T., Sparkes R.S., Kidd K.K., Amara S.G. Assignment of the norepinephrine transporterprotein (NET1) locus to chromosome 16. Genomics. 18:1993;690-692.
25. Giros B., E1 Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T., Caron M.G. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
26. Gu H.H., Ahn J., Caplan M.J., Blakely R.D., Levey A.I., Rudnick G. Cell-specific sorting of biogenic amine transporters expressed in epithelial cells. J. Biol. Chem. 271:1996;18100-18106.
27. Hahn M.K., Blakely R.D. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenom J. 2:2002;217-235.
28. Hahn M.K., Robertson D., Blakely R.D. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. J. Neurosci. 23:2003;4470-4478.
29. Hertting G., Axelrod J., Kopin I.J., Whitby L.G. Lack of uptake of catecholamines after chronic denervation of sympathetic nerves. Nature. 189:1961;66.
30. Iversen L.L. Uptake processes for biogenic amines. Iversen I. Handbook of Psychopharmacology, third ed. 1978;381-442 Plenum Press, New York.
31. Kantor L., Hewlett G.H., Park Y.H., Richardson-Burns S.M., Mellon M.J., Gnegy M.E. Protein kinase C and intracellular calcium are required for amphetamine- mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J. Pharmacol. Exp. Ther. 297:2001;1016-1024.
32. Kippenberger A.G., Palmer D.J., Comer A.M., Lipski J., Burton L.D., Christie D.L. Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells evidence for its association with secretory granules in PC12 cells . J. Neurochem. 73:1999;1024-1032.
33. Kitayama S., Ikeda T., Mitsuhata C., Sato T., Morita K., Dohi T. Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing. J. Biol. Chem. 274:1999;10731-10736.
34. Leitner B., Lovisetti-Scamihorn P., Heilmann J., Striessnig J., Blakely R.D., Eiden L.E., Winkler H. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerve. J. Neurochem. 72:1999;1110-1116.
35. Lingen B., Brüss M., Bönisch H. Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter. FEBS Lett. 342:1994;235-238.
36. Little K.Y., Elmer L.W., Zhong H., Scheys J.O., Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol. Pharmacol. 61:2002;436-445.
37. Lorang D., Amara S.G., Simerly R.B. Cell-type-specific expression of catecholamine transporters in the rat brain. J. Neurosci. 14:1994;4903-4914.
38. Lu D., Yu K., Paddy M.R., Rowland N.E., Raizada M.K. Regulation of norepinephrine transport system by angiotensin II in neuronal cultures of normotensive and spontaneously hypertensive rat brains. Endocrinology. 137:1996;763-772.
39. Masson J., Sagn C., Hamon M., Mestikawy S.E. Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51:1999;439-464.
40. Melikian H.E., Ramamoorthy S., Tate C.G., Blakely R.D. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol. Pharmacol. 50:1996;266-276.
41. Melikian H.E., McDonald J.K., Gu H., Rudnick G., Moore K.R., Blakely R.D. Human norepinephrine transporter biosynthetic studies using a site-directed polyclonal antibody . J. Biol. Chem. 269:1994;12290-12297.
42. Nelson N., Liu Q.R. Cloning of genes or cDNAs encoding neurotransmitter transporters and their localization by immunocytochemistry. Methods Enzymol. 296:1998;52-64.
43. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354.
44. Padbury J.F., Tseng Y., McGonnigal B., Penado K., Stephan M., Rudnick G. Placental biogenic amine transporters cloning and expression . Mol. Brain. Res. 45:1997;163-168.
45. Paxinos G.W.C. The Rat Brain in Stereotaxic Coordinates. second ed. 1986;Academic Press, San Diego, CA.
46. Phillips J.K., Dubey R., Sesiashvilvi E., Takeda M., Christie D.L., Lipski J. Differential expression of the noradrenaline transporter in adrenergic chromaffin cells, ganglion cells and nerve fibres of the rat adrenal medulla. J. Chem. Neuroanat. 21:2001;95-104.
47. Pickard L., Noel J., Duckworth J.K., Fitzjohn S.M., Henley J.M., Collingridge G.L., Molnar E. Transient synaptic activation of NMDA receptors leads to the insertion of native AMPA receptors at hippocampal neuronal plasma membranes. Neuropharmacology. 41:2001;700-713.
48. Qian Y., Galli A., Ramamoorthy S., Risso S., DeFelice L.J., Blakely R.D. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J. Neurosci. 17:1997;45-47.
49. Ramamoorthy S., Bauman A.L., Moore K.R., Han H., Yang-Feng T., Chang A.S., Ganapathy V., Blakely R.D. Antidepressant- and cocaine-sensitive human serotonin transporter molecular cloning, expression, and chromosomal localization . Proc. Natl. Acad. Sci. 90:1993;2542-2546.
50. Rudnick, G., 2002. Chemical modification strategies for structure-function studies, in: Michael W. Quick (Ed.), Transmembrane Transporters, Wiley, Europe, pp. 135-141.
51. Sakai N., Kodama N., Ohmori S., Sasaki K., Saito N. Involvement of the actin cytoskeleton in the regulation of serotonin transporter (SET) activity possible mechanism underlying SET regulation by protein kinase C . Neurochem. Int. 36:2000;567-579.
52. Saunders C., Ferrer J.V., Shi L., Chen J., Merrill G., Lamb M.E., Leeb-Lundberg L.M., Carvelli L., Javitch J.A., Galli A. Amphetamine-induced loss of human dopamine transporter activity an internalization-dependent and cocaine-sensitive mechanism . Proc. Natl. Acad. Sci. USA. 97:2000;6850-6855.
53. Schmid J.A., Scholze P., Kudlacek O., Freissmuth M., Singer E.A., Sitte H.H. Oligomerization of the human serotonin transporter and of the rat GABA transporter I visualized by fluorescence resonance energy transfer microscopy in living cells. J. Biol. Chem. 276:2001;3805-3810.
54. Schroeter S., Apparsundaram S., Wiley R.G., Miner L.H., Sesack S.R., Blakely R.D. Immunolocalization of the cocaine- and antidepressant-sensitive 1-norepinephrine transporter. J. Comp. Neurol. 420:2000;211-232.
55. Schwartz J.W., Blakely R.D., DeFelice L.J. Binding and transport in norepinephrine transporters real-time, spatially resolved analysis in single cells using a fluorescent substrate . J. Biol. Chem. 278:2003;9768-9777.
56. Shannon J.R., Flattem N.L., Jordan J., Jacob G., Black B.K., Biaggioni I., Blakely R.D., Robertson D. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N. Engl. J. Med. 342:2000;541-549.
57. Sumners C., Raizada M.K. Angiotensin II stimulates norepinephrine uptake in hypothalamus-brain stem neuronal cultures. Am. J. Physiol. 250:1986;C236-C244.
58. Sumners C., Shalit S.L., Kalberg C.J., Raizada M.K. Norepinephrine metabolism in neuronal cultures is increased by angiotensin II. Am. J. Physiol. 252:1987;C650-C656.
59. Sung U., Apparsundaram S., Galli A., Kahlig K.M., Savchenko V., Schroeter S., Quick M.W., Blakely R.D. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J. Neurosci. 23:2003;1697-1709.
60. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharmacol. 340:1997;249-258.
61. Torres G.E., Yao W.D., Mohn R.R., Quan H., Kim K., Levey A.I., Staudinger J., Caron M.G. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron. 30:2001;121-134.
62. Trendelenburg U. The TiPs lecture functional aspects of the neuronal uptake of noradrenaline . Trends Pharmacol. Sci. 32:1991;334-337.
63. Wang X., Yang H., Raizada M.K. Angiotensin II increases vesicular trafficking in brain neurons. Hypertension. 37:2001;677-682.
64. Wang Y.M., Xu F., Gainetdinov R.R., Caron M.G. Genetic approaches to studying norepinephrine function knockout of the mouse norepinephrine transporter gene . Biol. Psychiat. 46:1999;1124-1130.
65. Whitby L.G., Hertting G., Axelrod J. Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature. 187:1960;604-605.
66. Xu F., Gainetdinov R.R., Wetsel W.C., Jones S.R., Bohn L.M., Miller G.W., Wang Y.M., Caron M.G. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3:2000;465-471.